FDA 510(k) FDA class 2 Substantially Equivalent 🇺🇸 United States

EUROIMMUN IFA: Crithidia luciliae (anti-dsDNA) EUROPattern

K Number: K172244 · Decision Apr 20, 2018
Classifications
1
FEI Numbers
8
Registration Numbers
8
Same Product Code
18
Applicant Total
19
Review Days
268

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
EUROIMMUN IFA: Crithidia luciliae (anti-dsDNA) EUROPattern
K Number
K172244
Device Class
FDA class 2
Clearance Type
Traditional
Regulation Number
866.5100
Medical Specialty
Immunology
Decision
Substantially Equivalent
Statement or Summary
Statement
Applicant
Euroimmun Us, Inc.
Date Received
July 26, 2017
Decision Date
April 20, 2018
Product Code
KTL
Advisory Committee
Immunology
Review Advisory Committee
IM
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
KTL Anti-Dna Indirect Immunofluorescent Solid Phase

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (KTL), ordered by most recent decision date.

View all

Other Clearances by Euroimmun Us, Inc.

K Number Device Name
K193115 EUROIMMUN Anti-BP230-CF ELISA (IgG)
K183313 EUROIMMUN Anti-tissue Transglutaminase ELISA (IgA), EUROIMMUN Anti-tissue Transglutaminase ELISA (IgG)
K172582 EUROIMMUN IFA Granulocyte Mosaic™ EUROPattern and EUROIMMUN EUROPLUS Granulocyte Mosaic™ EUROPattern
K172252 EUROIMMUN IFA: Crithidia luciliae sensitive (anti-dsDNA) EUROPattern
K172722 Anti-Borrelia burgdorferi US EUROLINE-WB (IgM)
K153308 EUROIMMUN Anti-West Nile Virus ELISA (IgM)
K153303 EUROIMMUN Anti-West Nile Virus ELISA (IgG)
K141827 EUROIMMUN IFA 40: HEP-20-10; EUROPATTERN MICROSCOPE AND SOFTWARE
K132195 EUROIMMUN ANTI-PLA2R ELISA (IGG)
K100017 EUROIMMUN HIPPOCAMPUS/CEREBELLUM/GLUTAMATE RECEPTOR/IFA BIOCHIP MOSAIC TEST SYSTEM
Search all 19 clearances from Euroimmun Us, Inc. →